Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Licochalcone A suppresses migration and invasion of human hepatocellular carcinoma cells through downregulation of MKK4/JNK via NF-κB mediated urokinase plasminogen activator expression.

Tsai JP, Hsiao PC, Yang SF, Hsieh SC, Bau DT, Ling CL, Pai CL, Hsieh YH.

PLoS One. 2014 Jan 22;9(1):e86537. doi: 10.1371/journal.pone.0086537. eCollection 2014.

PMID:
24466137
[PubMed - in process]
Free PMC Article
2.

Licochalcone A inhibits the migration and invasion of human lung cancer cells via inactivation of the Akt signaling pathway with downregulation of MMP-1/-3 expression.

Huang HC, Tsai LL, Tsai JP, Hsieh SC, Yang SF, Hsueh JT, Hsieh YH.

Tumour Biol. 2014 Aug 23. [Epub ahead of print]

PMID:
25149157
[PubMed - as supplied by publisher]
3.

Butein inhibits the migration and invasion of SK-HEP-1 human hepatocarcinoma cells through suppressing the ERK, JNK, p38, and uPA signaling multiple pathways.

Ma CY, Ji WT, Chueh FS, Yang JS, Chen PY, Yu CC, Chung JG.

J Agric Food Chem. 2011 Aug 24;59(16):9032-8. doi: 10.1021/jf202027n. Epub 2011 Aug 3.

PMID:
21770460
[PubMed - indexed for MEDLINE]
4.

Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathway.

Chou RH, Hsieh SC, Yu YL, Huang MH, Huang YC, Hsieh YH.

PLoS One. 2013 Aug 5;8(8):e71983. doi: 10.1371/journal.pone.0071983. Print 2013.

PMID:
23940799
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.

Sliva D, English D, Lyons D, Lloyd FP Jr.

Biochem Biophys Res Commun. 2002 Jan 11;290(1):552-7.

PMID:
11779207
[PubMed - indexed for MEDLINE]
6.

miR-224 is critical for celastrol-induced inhibition of migration and invasion of hepatocellular carcinoma cells.

Li H, Li Y, Liu D, Sun H, Liu J.

Cell Physiol Biochem. 2013;32(2):448-58. doi: 10.1159/000354450. Epub 2013 Aug 27.

PMID:
23988648
[PubMed - indexed for MEDLINE]
7.

Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.

Chan CF, Yau TO, Jin DY, Wong CM, Fan ST, Ng IO.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4140-9.

PMID:
15217951
[PubMed - indexed for MEDLINE]
Free Article
8.

Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1.

Huang CS, Fan YE, Lin CY, Hu ML.

J Nutr Biochem. 2007 Jul;18(7):449-56. Epub 2006 Oct 17.

PMID:
17049831
[PubMed - indexed for MEDLINE]
9.

Antimetastatic effect and mechanism of ovatodiolide in MDA-MB-231 human breast cancer cells.

Lin KL, Tsai PC, Hsieh CY, Chang LS, Lin SR.

Chem Biol Interact. 2011 Nov 15;194(2-3):148-58. doi: 10.1016/j.cbi.2011.10.002. Epub 2011 Oct 19.

PMID:
22033475
[PubMed - indexed for MEDLINE]
10.
11.

S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.

Zhang J, Zhang DL, Jiao XL, Dong Q.

Eur Rev Med Pharmacol Sci. 2013 Sep;17(17):2372-82.

PMID:
24065232
[PubMed - indexed for MEDLINE]
Free Article
12.

Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.

Chen HJ, Lin CM, Lee CY, Shih NC, Peng SF, Tsuzuki M, Amagaya S, Huang WW, Yang JS.

Oncol Rep. 2013 Aug;30(2):925-32. doi: 10.3892/or.2013.2490. Epub 2013 May 23.

PMID:
23708932
[PubMed - indexed for MEDLINE]
13.

Antimetastatic effects of licochalcone A on oral cancer via regulating metastasis-associated proteases.

Shen H, Zeng G, Tang G, Cai X, Bi L, Huang C, Yang Y.

Tumour Biol. 2014 May 1. [Epub ahead of print]

PMID:
24789273
[PubMed - as supplied by publisher]
14.

Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.

Ko HS, Kim JS, Cho SM, Lee HJ, Ahn KS, Kim SH, Lee EO.

Bioorg Med Chem Lett. 2014 Feb 15;24(4):1176-9. doi: 10.1016/j.bmcl.2013.12.115. Epub 2014 Jan 7.

PMID:
24440300
[PubMed - in process]
Free Article
15.

Benzyl isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase-2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway.

Lai KC, Huang AC, Hsu SC, Kuo CL, Yang JS, Wu SH, Chung JG.

J Agric Food Chem. 2010 Mar 10;58(5):2935-42. doi: 10.1021/jf9036694.

PMID:
20136087
[PubMed - indexed for MEDLINE]
16.

Gypenosides inhibits migration and invasion of human oral cancer SAS cells through the inhibition of matrix metalloproteinase-2 -9 and urokinase-plasminogen by ERK1/2 and NF-kappa B signaling pathways.

Lu KW, Chen JC, Lai TY, Yang JS, Weng SW, Ma YS, Lu PJ, Weng JR, Chueh FS, Wood WG, Chung JG.

Hum Exp Toxicol. 2011 May;30(5):406-15. doi: 10.1177/0960327110372405. Epub 2010 May 28.

PMID:
20511288
[PubMed - indexed for MEDLINE]
17.

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.

Pulukuri SM, Gondi CS, Lakka SS, Jutla A, Estes N, Gujrati M, Rao JS.

J Biol Chem. 2005 Oct 28;280(43):36529-40. Epub 2005 Aug 26.

PMID:
16127174
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.

Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K.

Clin Cancer Res. 2007 Apr 1;13(7):2236-45.

PMID:
17404108
[PubMed - indexed for MEDLINE]
Free Article
19.

Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling.

Kwon GT, Cho HJ, Chung WY, Park KK, Moon A, Park JH.

J Nutr Biochem. 2009 Sep;20(9):663-76. doi: 10.1016/j.jnutbio.2008.06.005. Epub 2008 Sep 27.

PMID:
18824345
[PubMed - indexed for MEDLINE]
20.

Inhibition of uPAR and uPA reduces invasion in papillary thyroid carcinoma cells.

Nowicki TS, Kummer NT, Iacob C, Suslina N, Schaefer S, Schantz S, Shin E, Moscatello AL, Tiwari RK, Geliebter J.

Laryngoscope. 2010 Jul;120(7):1383-90. doi: 10.1002/lary.20915.

PMID:
20578104
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk